NCT06225362

Quatera 700 vs. Centurion

Evaluation and Clinical Outcomes After Routine Cataract Surgery With the Quatera® 700 and the Centurion® Vision System

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Carolina Eyecare Physicians, LLC · Academic / Other
• Sex: All
• Age: 50 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Phacoemulsification is the most common treatment for cataract surgery in the developed countries and over the years it gained importance due to several factors: small incision, surgery performed under topical anesthesia - which reduce injection-related complications - short recovery time, low post operatory induced astigmatism, and low incidence of surgical complications, when compared to the conventional surgeries. The study evaluates 2 different phacoemulsification devices in patients undergoing routine cataract surgery in both eyes.

Conditions

• Cataract

Interventions

Type	Name	Description
DEVICE	Quatera 700	Phacoemulsification device
DEVICE	Centurion	Phacoemulsification device

Timeline

• Start date: 2024-01-10
• Primary completion: 2025-10-06
• Completion: 2025-10-06
• First posted: 2024-01-25
• Last updated: 2026-04-01
• Results posted: 2026-04-01

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study